BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

268 related articles for article (PubMed ID: 21480388)

  • 1. Fyn is induced by Ras/PI3K/Akt signaling and is required for enhanced invasion/migration.
    Yadav V; Denning MF
    Mol Carcinog; 2011 May; 50(5):346-52. PubMed ID: 21480388
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The inhibition of SRC family kinase suppresses pancreatic cancer cell proliferation, migration, and invasion.
    Je DW; O YM; Ji YG; Cho Y; Lee DH
    Pancreas; 2014 Jul; 43(5):768-76. PubMed ID: 24763074
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Targeting Fyn in Ras-transformed cells induces F-actin to promote adherens junction-mediated cell-cell adhesion.
    Fenton SE; Hutchens KA; Denning MF
    Mol Carcinog; 2015 Oct; 54(10):1181-93. PubMed ID: 24976598
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Deficiency of Fyn protein is prerequisite for apoptosis induced by Src family kinase inhibitors in human mesothelioma cells.
    Eguchi R; Kubo S; Takeda H; Ohta T; Tabata C; Ogawa H; Nakano T; Fujimori Y
    Carcinogenesis; 2012 May; 33(5):969-75. PubMed ID: 22354875
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Both src-dependent and -independent mechanisms mediate phosphatidylinositol 3-kinase regulation of colony-stimulating factor 1-activated mitogen-activated protein kinases in myeloid progenitors.
    Lee AW; States DJ
    Mol Cell Biol; 2000 Sep; 20(18):6779-98. PubMed ID: 10958675
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Opposite regulation by PI3K/Akt and MAPK/ERK pathways of tissue factor expression, cell-associated procoagulant activity and invasiveness in MDA-MB-231 cells.
    Hu C; Huang L; Gest C; Xi X; Janin A; Soria C; Li H; Lu H
    J Hematol Oncol; 2012 Jul; 5():16. PubMed ID: 22534171
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prostate cancer ETS rearrangements switch a cell migration gene expression program from RAS/ERK to PI3K/AKT regulation.
    Selvaraj N; Budka JA; Ferris MW; Jerde TJ; Hollenhorst PC
    Mol Cancer; 2014 Mar; 13():61. PubMed ID: 24642271
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Overexpression of FYN suppresses the epithelial-to-mesenchymal transition through down-regulating PI3K/AKT pathway in lung adenocarcinoma.
    Xue F; Jia Y; Zhao J
    Surg Oncol; 2020 Jun; 33():108-117. PubMed ID: 32561075
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Early adhesion induces interaction of FAK and Fyn in lipid domains and activates raft-dependent Akt signaling in SW480 colon cancer cells.
    Baillat G; Siret C; Delamarre E; Luis J
    Biochim Biophys Acta; 2008 Dec; 1783(12):2323-31. PubMed ID: 18805444
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Fyn and SRC are effectors of oncogenic epidermal growth factor receptor signaling in glioblastoma patients.
    Lu KV; Zhu S; Cvrljevic A; Huang TT; Sarkaria S; Ahkavan D; Dang J; Dinca EB; Plaisier SB; Oderberg I; Lee Y; Chen Z; Caldwell JS; Xie Y; Loo JA; Seligson D; Chakravari A; Lee FY; Weinmann R; Cloughesy TF; Nelson SF; Bergers G; Graeber T; Furnari FB; James CD; Cavenee WK; Johns TG; Mischel PS
    Cancer Res; 2009 Sep; 69(17):6889-98. PubMed ID: 19690143
    [TBL] [Abstract][Full Text] [Related]  

  • 11. H-Ras-specific activation of Rac-MKK3/6-p38 pathway: its critical role in invasion and migration of breast epithelial cells.
    Shin I; Kim S; Song H; Kim HR; Moon A
    J Biol Chem; 2005 Apr; 280(15):14675-83. PubMed ID: 15677464
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The protein phosphatase activity of PTEN regulates SRC family kinases and controls glioma migration.
    Dey N; Crosswell HE; De P; Parsons R; Peng Q; Su JD; Durden DL
    Cancer Res; 2008 Mar; 68(6):1862-71. PubMed ID: 18339867
    [TBL] [Abstract][Full Text] [Related]  

  • 13. FYN promotes breast cancer progression through epithelial-mesenchymal transition.
    Xie YG; Yu Y; Hou LK; Wang X; Zhang B; Cao XC
    Oncol Rep; 2016 Aug; 36(2):1000-6. PubMed ID: 27349276
    [TBL] [Abstract][Full Text] [Related]  

  • 14. FYN: emerging biological roles and potential therapeutic targets in cancer.
    Peng S; Fu Y
    J Transl Med; 2023 Feb; 21(1):84. PubMed ID: 36740671
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Src family kinases are required for prolactin induction of cell proliferation.
    Fresno Vara JA; Cáceres MA; Silva A; Martín-Pérez J
    Mol Biol Cell; 2001 Jul; 12(7):2171-83. PubMed ID: 11452011
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Muscarinic acetylcholine receptors mediate oligodendrocyte progenitor survival through Src-like tyrosine kinases and PI3K/Akt pathways.
    Cui QL; Fogle E; Almazan G
    Neurochem Int; 2006 Apr; 48(5):383-93. PubMed ID: 16439036
    [TBL] [Abstract][Full Text] [Related]  

  • 17. FYN expression potentiates FLT3-ITD induced STAT5 signaling in acute myeloid leukemia.
    Chougule RA; Kazi JU; Rönnstrand L
    Oncotarget; 2016 Mar; 7(9):9964-74. PubMed ID: 26848862
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The Role of TLR4 and Fyn Interaction on Lipopolysaccharide-Stimulated PAI-1 Expression in Astrocytes.
    Ko HM; Lee SH; Kim KC; Joo SH; Choi WS; Shin CY
    Mol Neurobiol; 2015 Aug; 52(1):8-25. PubMed ID: 25106729
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Impact of oncogenic driver mutations on feedback between the PI3K and MEK pathways in cancer cells.
    Yuen HF; Abramczyk O; Montgomery G; Chan KK; Huang YH; Sasazuki T; Shirasawa S; Gopesh S; Chan KW; Fennell D; Janne P; El-Tanani M; Murray JT
    Biosci Rep; 2012 Aug; 32(4):413-22. PubMed ID: 22668349
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Src kinases in chondrosarcoma chemoresistance and migration: dasatinib sensitises to doxorubicin in TP53 mutant cells.
    van Oosterwijk JG; van Ruler MA; Briaire-de Bruijn IH; Herpers B; Gelderblom H; van de Water B; Bovée JV
    Br J Cancer; 2013 Sep; 109(5):1214-22. PubMed ID: 23922104
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.